Artikel von Marvin Herzberger
Marvin Herzberger is a publishing trader at TraderFox GmbH and group leader for the technical analysis of the DAX. He has been actively engaged in technical analysis since 2011. In this context, he has tested, analyzed, and evaluated various trading strategies in practical implementation. His area of expertise lies in swing trading. The analyses cover a short-term time horizon of up to 10 days.Latest from Marvin Herzberger
Fuelcell Energy: Price Target of 30 USD Meets Billion-Dollar Order Backlog
The strategic focus on data centers drives the order backlog of Fuelcell Energy (FCEL) to over 3.6 billion...
Robinhood Markets: Crypto and Subscriptions Support Analysts’ $136 Price Target!
Diversification: New revenue sources reduce reliance on pure trading business. Scotiabank Analysis:...
Microsoft: CEO Stock Sale and New Reporting Structure in Investors' Focus
Adjustment of reporting segments starting from the fiscal year 2027 reflects the structural relevance...
Soitec: Market Dominance in Optical Networks Enables Strong Forecast!
Regarding Soitec (i.), I have already reported several times since the presentation of the Q1 report...
Novo Nordisk: Pills Instead of Injections - Obesity Therapies Offer Long-Term Potential!
For investors currently seeking diversification in the healthcare sector, I find Novo Nordisk (i.) interesting....
Caterpillar: Billion-Dollar Order Backlog Meets New AI Alliance
Infrastructure trends drive the order backlog to around $72 billion. The partnership with FieldAI...
Fervo Energy Company: 400 MW Contract with Google and Over 150% Upside Potential!
Fervo Energy (FRVO) employs modified drilling techniques for weather-independent, emissions-free geothermal...
MP Materials: The Invisible Building Block for the Next Generation of Robotics
MP Materials is gradually expanding its business model from pure raw material extraction to full magnet...
Duolingo: 170,000 Tracked App Users Trigger Analyst Upgrade With a Doubling of the Price Target!
Share price benefits from upgrades by Evercore ISI and DA Davidson on September 1. Strong user...
Latigo Biotherapeutics: Guggenheim's buy recommendation with over 100% upside potential draws attention to NaV1.8 inhibitors
Latigo Biotherapeutics (LTGO) focuses on non-opioid analgesics for acute and chronic pain. On September...
Novartis: Trend Followers Receive a Fresh Buy Signal Based on Study Data!
Novartis is a European pharmaceutical heavyweight offering a compelling long-term investment story. This...
Deere: AI Assistant “JD” Drives the Next Phase of Agricultural Digitalization
Transformation into a tech company: Deere is increasingly focusing on smart farming and software-based...
BioMarin: Settled Patent Dispute with Ascendis Pharma Brings Stable Cash Flows Until 2030!
BioMarin achieves a far-reaching settlement in the patent dispute over the drug Yuviwel with Ascendis...
Klarna: CEO Invests $10 Million – I'm Following the Insider!
Klarna (KLAR) (i.) recently reported a strong Q2. Revenue rose by 27% to $1.04 billion, and the transaction...
SAIC: Unprofitable Contracts Give Way to a Targeted Profitability Strategy!
Strict cost discipline and the separation from unprofitable project legacies shatter analyst estimates....
Attovia Therapeutics Inc.: Leerink Initiates Coverage on Stock After Successful IPO with Price Target of $52!
Attovia Therapeutics (ATTO) develops complex biologics for immune-mediated diseases using its proprietary...
Super Micro Computer: Over $60 Billion in Order Intake Secures Growth for 2027!
For speculative investors, Super Micro Computer (SMCI) (i.) is currently worth a look again. The company...
Klarna Group: Record Margins, Leadership Change, and a $10 Million Investment
The core business is growing profitably, driven by significantly higher margins. Despite strong...
Eli Lilly: FDA Approval for Mounjaro for Cardiovascular Prevention Opens New Billion-Dollar Markets
Mounjaro and Zepbound drove a revenue growth of 48% to $23.0 billion in the second quarter. The...
Iren Ltd.: From Post-Earnings Sell-Off to $90 Target - H.C. Wainwright Sees a Buying Opportunity
Iren Ltd. (IREN) is undergoing a strategic shift from Bitcoin mining to AI cloud infrastructure. The...